BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37888771)

  • 1. Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner.
    Lee DY; Lee S; Kim YS; Park S; Bae SM; Cho EA; Park EJ; Park HH; Kim SY; So I; Chun JN; Jeon JH
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37888771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geraniol suppresses prostate cancer growth through down-regulation of E2F8.
    Lee S; Park YR; Kim SH; Park EJ; Kang MJ; So I; Chun JN; Jeon JH
    Cancer Med; 2016 Oct; 5(10):2899-2908. PubMed ID: 27683099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
    Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
    Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
    Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
    PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
    Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
    Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway.
    Bainbridge A; Walker S; Smith J; Patterson K; Dutt A; Ng YM; Thomas HD; Wilson L; McCullough B; Jones D; Maan A; Banks P; McCracken SR; Gaughan L; Robson CN; Coffey K
    Nucleic Acids Res; 2020 Jun; 48(10):5366-5382. PubMed ID: 32324216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
    Wang LG; Johnson EM; Kinoshita Y; Babb JS; Buckley MT; Liebes LF; Melamed J; Liu XM; Kurek R; Ossowski L; Ferrari AC
    Cancer Res; 2008 Apr; 68(8):2678-88. PubMed ID: 18413735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
    Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
    Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma.
    Yu H; Zhang D; Li Z; Wang M
    Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
    Tian J; Lin Y; Yu J
    Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
    Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice.
    Karan D; Dubey S; Gunewardena S; Iczkowski KA; Singh M; Liu P; Poletti A; Choo YM; Chen HZ; Hamann MT
    Mol Oncol; 2024 Apr; ():. PubMed ID: 38605607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
    Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
    Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
    Peacock SO; Fahrenholtz CD; Burnstein KL
    Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression.
    Blessing AM; Rajapakshe K; Reddy Bollu L; Shi Y; White MA; Pham AH; Lin C; Jonsson P; Cortes CJ; Cheung E; La Spada AR; Bast RC; Merchant FA; Coarfa C; Frigo DE
    Autophagy; 2017 Mar; 13(3):506-521. PubMed ID: 27977328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
    Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H
    Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
    Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
    Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression.
    Goel S; Bhatia V; Kundu S; Biswas T; Carskadon S; Gupta N; Asim M; Morrissey C; Palanisamy N; Ateeq B
    Nat Commun; 2021 Sep; 12(1):5325. PubMed ID: 34493733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.